Guidance for market authorization requirements for COVID-19 vaccines: Rolling submissions, non-clinical and clinical requirements (English, HTML)
View metadata and access the original English HTML file: Guidance for market authorization requirements for COVID-19 vaccines: Rolling submissions, non-clinical and clinical requirements.
- Format
- HTML
- Access
- file-only
- Publisher-reported update
- 2022-07-28
This document provides guidance on the standard for accepting a rolling submission and non-clinincal requirements for authorization.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file